Cells Tissues Organs · 2008 · 98 citations · 7 references
Life SciencesCell BiologyMolecular BiologyBone MetabolismGene ExpressionStem Cell BiologyAdipocyte DifferentiationBone DevelopmentBone FormationBone RegenerationOsteoblast BiologyOsteogenesisAdipocyte BiologyBone Marrow - Derived CellsBone Marrow AdipocytesBone Marrow Mesenchymal Stem CellsPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsSirtuin 1 Regulation
Mesenchymal stem cells (MSC) can differentiate into osteoblasts, adipocytes, chondrocytes and myoblasts. It has been suggested that a reciprocal relationship exists between the differentiation of MSC into osteoblasts and adipocytes. Peroxisome proliferator-activated receptor gamma2 (PPARgamma2) is a key element for the differentiation into adipocytes. Activation of the nuclear protein deacetylase Sirt1 has recently been shown to decrease adipocyte development from preadipocytes via inhibition of PPARgamma2. In vitro, MSC differentiate to osteoblasts when exposed to bone-inducing medium. However, adipocytes are also developed. In the present study we have targeted Sirt1 to control adipocyte development during differentiation of MSC into osteoblasts. The finding that resveratrol and isonicotinamide markedly inhibited adipocyte and promoted osteoblast differentiation demonstrates an interesting alternative to PPARgamma antagonists. These results are important for the evolving field of cell-based tissue engineering, but may also be relevant in the search for new treatments of osteoporosis.
7
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Frédéric Picard, Martin V. Kurtev, Acharawan Topark‐Ngarm et al. · Nature · 2004 · 1.9K citations · Full text
Bone Is a Target for the Antidiabetic Compound Rosiglitazone
Sylwia Rzońca, Larry J. Suva, Dana Gaddy et al. · Endocrinology · 2003 · 452 citations · Full text